Med Quiz II Flashcards Preview

Women's Health Med Quizzes > Med Quiz II > Flashcards

Flashcards in Med Quiz II Deck (40)
Loading flashcards...

terbutaline sulfate: classification



Terbutaline sulfate: indications

  • tocolytic: management of preterm labor-->inhibition of uterine contractions


Terbutaline sulfate: ADRs

  • CV: maternal and fetal tachycardia, palpitations, cardiac dysrhythmias, chest pain, wide pulse pressure
  • resp: dyspnea, chest discomfort
  • CNS: tremors, restlessness, weakness, HA, dizziness
  • metabolic: hypokalemia, hyperglycemia
  • GI: n/v, reduced bowel motility
  • skin: flushing, diaphoresis


Terbutaline sulfate: nursing implications

  • not approved by the FDA for use as a tocolytic
  • do not use for longer than 48-72 hour
  • assess woman's apical HR and lung sounds before administering each dose
    • drug toxicity and d/c drug if: maternal HR over 120 bpm or respiratory findings such as "wet" lung sounds or more rapid rate
  • report all non-reassuring maternal and fetal assessments to physician
  • have propranolol ready as a reversal agent


nifedipine: classification

tocolytic; CCB


Nifedipine: indications

  • CCB used for tocolysis
    • reduce uterine contractions b/c Ca is essential for muscular contractions (for preterm labor)


nifedipine: contraindications

  • AV heart block
  • systolic BP <90
  • coadministration with grapefruit juice


Nifedipine: ADRs

  • flushing
  • HA
  • inc in maternal and fetal HR
  • maternal postural hypotension
  • hyperglycemia
  • will cause the FHR to have reduced variability


Nifedipine: nursing implications

  • observe for SEs
  • report maternal pulse greater than 120 bpm
  • educate on possible dizziness or faintness
    • sit or stand slowly and call for assistance if needed
  • never give with mag sulfate


Nifedipine: dosage

  • Give 10-20 mg/3-6 hours until contractions become rare or stop


betamethasone: classification



Betamethasone: indications

  • acceleration of fetal lung maturity to reduce the incidence and severity of respiratory distress syndrome (RDS)
    • greatest benefits if at least 24 hrs elapse b/w initial dose and birth of preterm infant
    • indicated if gestation b/w 24-34 wks


betamethasone: contraindications

  • active infection, such as chorioamnionitis


Betamethasone: ADRs

  • few b/c short term use of drug
  • pulmonary edema possible secondary to sodium and fluid retention
  • fever and elevated pulse rate secondary to infection
  • UTI
  • hyperglycemia


Betamethasone: nursing considerations

  • educate woman on potential benefits, but tell her drug cannot prevent all complications of prematurity
  • if woman has diabetes, more frequent blood glucose checks are needed
  • WBCs greater than 20,000 may indicate infection
    • but may have a temporary rise in platelets and WBCs for 72 hours that is expected
  • assess lung sounds 
  • report chest pain, heaviness, or dyspnea
  • report pain or burning with urination
  • assess V/S for fever and elevated pulse


indomethacin: classification

ductus arteriosus patency adjunct


Indomethacin: indications

  • tocolytic: to inhibit uterine contractions (for preterm labor)
  • can be used to normalize volume of amniotic fluid if hydramnios is present


indomethacin: contraindications

  • alcohol intolerance
  • active GI bleed
  • ulcer dz
  • thrombocytopenia
  • use of NSAIDs


Indomethacin: ADRs

  • Maternal:
    • GI: n/v/heartburn
    • asthm ain aspirin sensitive women
    • inc BP in hypertensive women
  • Fetal:
    • constriction of ductus arteriosus
    • pulmonary HTN
    • oligohydramnios (usually returns to normal when drug is d/c)


Indomethacin: nursing implications

  • limit use to preterm labor before 32 weeks gestation
  • use for no longer than 48-72 consecutive hours
  • observe for GI SEs
  • observe for abnormal bleeding (such as prolonged bleeding after injection and bruising with no apparent cause)
  • watch for signs of infection, b/c drug may mask them
  • check height of fundus at beginning of therapy and daily thereafter to identify reduced amniotic fluid
  • observe for decreased fetal movements and absent FHR accelerations w/ fetal movement (may indicate fetal condition deteriorating)
  • use U/S and fetal echocardiography to determine if drug having adverse effects on fetus


Carboprost tromethamine: classification

oxytoxics; prostaglandins


Carboprost tromethamine: Indications

  • Used for tx of postpartum hemorrhage caused by uterine atony
  • Abortion


carboprost tromethamine: contraindications

  • acute PID
  • asthma
  • active pulmonary, hepatic, or renal dz
  • use carefully if uterine scarring is present


Carboprost Tromethamine: ADRs

  • Tetanic contraction and laceration
  • Uterine rupture
  • Uterine hypertonus if used w/ oxytocin
  • n/v/d
  • Fever
  • Flushing
  • HA
  • HTN or hypoTN
  • Tachycardia
  • Pulmonary edema


Carboprost tromethamine: Nursing implications

  • Refrigerate drug
  • Give via deep IM injection and aspirate carefully to avoid IV injection
  • Rotate sites if repeated
  • Monitor V/S
  • Administer antiemetics and antidiarrheals as ordered


Methylergonovine: classification

ergo-alkaloid and oxytoxic


Methylergonovine: indications

  • Used for prevention and tx of postpartum or postabortion hemorrhage caused by uterine atony or subinvolution


methylergonovine: contraindications

  • should not be used to induce labor
  • do not breastfeed during tx and for 12 hours after the last dose
  • use cautiously in eclamptic patients
  • exercise extreme caution in the 3rd stage of labor


Methylergonovine: ADRs

  • n/v
  • Uterine cramping
  • HTN
  • Dizziness
  • HA
  • Dyspnea
  • Chest pain
  • Palpitations
  • Peripheral ischemia
  • Seizure
  • Uterine and GI cramping


Methylergonovine: Nursing implications

  • Before admin, assess BP
    • Withhold if hospital policy says you should at a certain level
  • Tell mother to avoid smoking b/c constricts vessels and will inc BP
  • Report any ADRs